awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q38643755-0EEF040E-F3C2-447E-BDEF-525CF51897C0
Q38643755-0EEF040E-F3C2-447E-BDEF-525CF51897C0
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38643755-0EEF040E-F3C2-447E-BDEF-525CF51897C0
Lupus nephritis and B-cell targeting therapy.
P2860
Q38643755-0EEF040E-F3C2-447E-BDEF-525CF51897C0
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38643755-0EEF040E-F3C2-447E-BDEF-525CF51897C0
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
845af4db93de363b17deb5ecbf48d29108feb1fe
P2860
A phase 2, randomised, placebo-controlled clinical trial of blisibimod, an inhibitor of B cell activating factor, in patients with moderate-to-severe systemic lupus erythematosus, the PEARL-SC study.